The “Éclair Diet” and Prostate Cancer
Jacob Schor, ND, FABNO; With Tina Kaczor, ND, FABNO The “éclair diet” has us completely rethinking what to tell men with advanced prostate cancer. It also has us pondering the […]
Jacob Schor, ND, FABNO; With Tina Kaczor, ND, FABNO The “éclair diet” has us completely rethinking what to tell men with advanced prostate cancer. It also has us pondering the […]
Dr Jillian Stansbury Approximately half of all men experience some symptoms of prostatic hypertrophy in the latter decades of life,1 and American men have an 18% chance of developing prostate
Katherine Neubauer, ND Heliotherapy, the therapeutic use of sunlight, has long been a core treatment in naturopathic medicine. Current understanding of vitamin Ds importance in oncology supports its value. With
Anne Marie Fine, NMD and Sara Rodgers, NMD, MS Naturopathic physicians are experts in helping people decide what to put in the body; we are also well-positioned to provide expert
Gurdev Parmar, ND, FABNO I took my third trip to Germany in spring 2009 to visit some cancer “kliniks” there. There were 4 reasons that prompted that trip. First, my
Heather Paulson, ND, FABNO The number of adults who have survived childhood cancer is rapidly increasing. The likelihood that NDs will be responsible for monitoring the late effects of cancer
Aminah A. Keats, ND, FABNO Ever since oophorectomy was first shown to cause regression of advanced breast cancer more than a century ago, deprivation of estrogenic signaling has been the
Virginia Osborne, ND As NDs we are often confronted with chronic diseases that precipitate, or are precipitated by, inflammation. These are the cases that often lead us to determine that
Jacob Schor, ND, FABNO Eucalyptus oil may be a useful adjunct to consider for patients undergoing cancer chemotherapy. This essential oil may activate innate cell-mediated immune responses and counter the
Clinical rule out strategies for an elevated tPSA Phranq D. Tamburri, NMD Your 60-year-old male patient presents to you with an ‘elevated’ total prostate specific antigen (tPSA) of 3.5 ng/ml.